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BACKGROUND AND PURPOSE: Intracranial fusiform aneurysms, which incorporate the branch vessel
and require salvaging of the parent vessel, are difficult to manage. The goal of this study was to
evaluate the efficacy of reconstructive endovascular treatment of intracranial fusiform aneurysms by
using a 1-stage procedure with a stent and balloon.
MATERIALS AND METHODS: During a 3-year period, 20 patients with 20 intracranial fusiform aneu-
rysms were treated by using a 1-stage procedure involving a balloon and stent. Subarachnoid hemor-
rhage was present in 15 patients. Five aneurysms were located in the anterior circulation and 15, in the
posterior circulation. Clinical outcomes and periprocedural complications were evaluated in all patients.
The extent of coil packing was evaluated by control angiography after embolization and classified as
either complete occlusion or partial occlusion. Angiography was performed 6, 12, and 24 months after
embolization to evaluate stent patency and coil packing.
RESULTS: The 1-stage procedure by using a combination of balloon and stent was technically suc-
cessful in all patients. There were no complications related to the procedure, complete occlusion was
obtained in 16 patients, and partial occlusion, in 4 patients. All patients recovered well except for 2 who
died due to causes unrelated to the procedure. Clinical follow-up was performed in all surviving
patients at a mean of 12.3 months (range, 7–24 months), and angiography showed that the patent
parent arteries were free of aneurysm recanalization or in-stent stenosis.
CONCLUSIONS: This 1-stage procedure may provide a feasible and safe treatment strategy for the
management of intracranial fusiform aneurysms that are not amenable to deconstructive embolization.
Intracranial fusiform aneurysms (IFAs) are categorized asnonsaccular aneurysms based on their morphology. These
nonsaccular or truncal aneurysms are not common, and their
origin is unclear. Some authors have even speculated that they
may originate as a result of dissection and that the etiology of
dissection may be congenital or acquired.1-3
Although the indications for treatment are controversial in
these aneurysms, vigorous treatment is mandatory in some
circumstances, for example, in ruptured aneurysms or symp-
tomatic lesions. The treatment of IFAs that contain branching
vessels is particularly challenging for interventional neurora-
diologists or neurosurgeons.
Recently, a few studies have reported endovascular treat-
ment of IFAs by using a stent and balloon simultaneously.4,5
We report the clinical outcomes and 2-year follow-up results
of endovascular treatment of 20 IFAs by using a 1-stage pro-
cedure that involves the concurrent use of a balloon and stent.
Materials and Methods
Patients
We enrolled 20 patients with 20 IFAs from among patients with 312
aneurysms between September 2005 and September 2008 (mean age,
54 years; male:female ratio, 8:12). Medical information and angio-
grams were reviewed retrospectively. This study was approved by the
institutional review board, and written informed consent was ob-
tained from all 20 patients before the 1-stage procedure.
Five aneurysms were located in the internal carotid artery (ICA);
11, in the distal vertebral artery (VA); 2, in the vertebrobasilar junc-
tion (VBJ); and 2, in the basilar artery (BA).
Subarachnoid hemorrhage (SAH) was present in 15 aneurysms,
and 5 aneurysms were found incidentally. Using the Hunt and Hess
(HH) grading system, we classified aneurysms in 6 patients as HH
grades 4–5, 9 patients asHHgrades 1–3, and 5 patients asHHgrade 0.
Eleven of the VA/VBJ fusiform aneurysms incorporated a branch-
ing vessel (posterior inferior cerebellar artery [PICA] or anterior in-
ferior cerebellar artery [AICA]). The contralateral VAwas hypoplastic
in the remaining 2 aneurysms. IFAs that did not incorporate a
branching vessel or had an involved VA that was equivalent to a con-
tralateral VA were excluded from this study.
Endovascular Technique
All the procedures were performed with the patient under general
anesthesia. In 15 cases, coil embolization was performed immediately
after diagnostic cerebral angiography, and 5 procedures were per-
formed electively. All patients had full heparinization (activated clot-
ting time, 300 seconds) during the coil embolization, and hepa-
rinizationwasmaintained for 24 hours after the procedure. In elective
cases, dual antiplatelet medication (clopidogrel, 75 mg/day, and aspi-
rin, 325 mg/day) was initiated 3–5 days before the procedure. In
emergency cases, clopidogrel, 300 mg, and aspirin, 500 mg, were ad-
ministered immediately after the procedure, and heparinization was
maintained 24 hours after the procedure (activated clotting time,
300 seconds).
For the reconstructive endovascular treatment of IFAs, a 6F guid-
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ing catheter system (Envoy; Cordis Neurovascular, Miami Lakes,
Florida) or a 6F Shuttle introducer system (Cook, Bloomington, In-
diana) was introduced via the femoral artery. In the first step of the
1-stage procedure, a Neuroform stent (Boston Scientific, Natick,
Massachusetts), Multilink Zeta (Guidant, Santa Clara, California), or
Flexmaster F1 (Abbott Vascular, Rangendingen, Germany) was de-
ployed across the aneurysm neck to preserve the parent artery and
incorporating vessel. In the second step, which was performed se-
quentially, a microcatheter (Prowler 14 microcatheter, Cordis
Neurovascular; Excelsior SL-10microcatheter, Boston Scientific) was
advanced carefully into the aneurysm through the stent struts, and
an occlusion balloon catheter (HyperGlide [4  15/20 mm]; ev3,
Irvine, California) was placed inside the stent to protect the parent
vessel lumen from protrusion of the coil loop and to stabilize the
microcatheter. During temporary inflation of the occlusion balloon
within the stent, the coil was delivered into the aneurysm sac via the
microcatheter. The temporary occlusion balloon was deflated to ver-
ify coil protrusion and in-stent thrombosis of the parent artery and
patency of the incorporated branching vessel before coil detachment.
This process was repeated until coil embolization was accomplished
adequately. A closure device (Angio-Seal; St. Jude Medical, St. Paul,
Minnesota) was used to seal off the femoral artery puncture. All
treated patients were maintained with heparin for 24 hours after the
procedure and clopidogrel, 75 mg/day, and aspirin, 150 mg/day, for
6 months.
Clinical Outcomes and Follow-Up
Patients were evaluated by angiography to confirm the exclusion of
the aneurysm and the patency of the incorporated vessels immedi-
ately after the procedure. Angiographic results were classified as either
complete occlusion (no filling of contrast agent in the aneurysm sac)
or partial occlusion (residual filling of contrast agent in the rem-
nant aneurysm sac). Periprocedural and postoperative complica-
tions, such as thromboembolism (TE), parent artery occlusion, re-
bleeding, in-stent thrombosis, and retroperitoneal hematoma, were
also evaluated.
Angiography was performed 6, 12, and 24 months after emboli-
zation to assess recanalization of the coiled aneurysm and the patency
of the stent and incorporated vessels. Compared with the initial an-
giography, these follow-up angiograms were reviewed and classified
as a change in the initial angiographic results by 2 senior neuroradi-
ologists (D.I.K., T.-S.C.). Clinical outcome was evaluated according
to the modified Rankin Scale (mRS) 6, 12, and 24 months after
discharge.
Results
The 1-stage embolization procedure by using a balloon and
stent was technically successful in all 20 IFAs of the 20 patients.
There were no procedural complications in any patients with
the exception of patient 5, and 18 patients recovered well with
normal neurologic signs (mRS 0–1). Two patients with a poor
initial HH grade died due to causes unrelated to the procedure
1 week after the embolization.
In the 18 surviving patients, complete occlusion was ob-
tained in 14 aneurysms, and 4 aneurysms had partial occlusion
because attemptsweremade to incorporate the branching ves-
sel or because the location and low profile of the aneurysm
made it difficult to catheterize. A single stent was used in all
except 5 patients. In these 5 patients, a second stent was de-
ployed successively into the stented segment of the parent ar-
Patient Characteristics and Clinical Outcomes
No Sex
Age
(yr)
Presentation
(HH) Location
Branch
Vessel
Size
(mm) Stent (mm) Occlusion
Procedural
Complication mRS
F/U
Angiography
F/U
(mo)
1 M 46 Incidental (0) LVA PICA 8 Neuroform 4  20 P None 0 IO 24
2 M 50 SAH (5) LVA N 8 Zeta coronary stent
3  38
C None Death NA
3 M 32 Incidental (0) LICA N 4 Neuroform 4  20 C None 0 CO 11
4 F 62 Incidental (0) LVA PICA 6 Neuroform 4  20 C None 0 CO 13
5 F 40 SAH (4) LVA PICA 6 Neuroform 4  20 P Rebleeding due
to coil
1 IO 14
Flexmaster 3  16
6 F 55 SAH (3) RVA PICA 5 Neuroform 4  20 C None 0 CO 11
7 F 60 SAH (4) LVA PICA 7 Neuroform 4  20 C None 1 CO 13
8 F 45 SAH (4) BA N 6 Neuroform 4  20 C None 0 CO 11
9 F 42 SAH (3) RVA PICA 8 Neuroform 4  20 P None 1 IO 13
10 F 66 SAH (3) RVA PICA 6 Neuroform 4  20 C None 0 CO 15
11 M 50 SAH (3) LVA PICA 7 Neuroform 4  20 C None 1 CO 12
Neuroform 4  20
12 F 62 Incidental (0) RICA N 9 Neuroform 4  20 C None 0 CO 7
13 F 60 Incidental (0) RICA N 9 Neuroform 4  20 C None 0 CO 8
14 F 45 SAH (5) VBJ AICA 16 Neuroform 4.5  20 C None Death NA 10
15 M 49 SAH (2) RICA N 3 Neuroform 4  15 P None 1 CO 10
Neuroform 4  20
16 M 67 SAH (3) VBJ N 6 Neuroform 4.5  20 C None 0 CO 11
Neuroform 4.5  15
17 M 51 SAH (4) RVA PICA 4 Neuroform 4  20 C None 1 CO 10
Neuroform 4.5  20
18 F 74 SAH (3) LICA N 5 Neuroform 4  20 C None 0 CO 10
19 M 78 SAH (2) BA N 5 Neuroform 4  20 C None 1 CO 10
20 F 49 SAH (3) LVA PICA 5 Neuroform 4  20 C None 1 CO 8
Note:—HH indicates Hunt and Hess grading scale; SAH, subarachnoid hemorrhage; LVA, left vertebral artery; RVA, right vertebral artery; VBJ, vertebrobasilar junction; BA, basilar artery;
RICA, right intracranial artery; LICA, left intracranial artery; P, partial; C, complete; F/U, follow-up period; mRS: modified Rankin Scale; NA, not available; IO, incomplete occlusion; CO,
complete occlusion; PICA, posterior inferior cerebellar artery; AICA, anterior inferior cerebellar artery; N, no branching vessel.
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tery because of aneurysm rupture, unpredictable coil protru-
sion, or in-stent thrombosis. There was good patency of all
the incorporated branching vessels at the conclusion of the
procedure.
The follow-up period was 7–24 months (mean, 12.3
months). Follow-up angiographies were performed in all 18
surviving patients and showed incomplete occlusion in 3 pa-
tients who had partial occlusion at the initial treatment, stable
occlusion in 14 patients, and progressive occlusion with fur-
ther thrombosis in 1 patient. During the follow-up period,
there was no evidence of in-stent stenosis, occlusion of the
incorporated branching vessel, or coil compaction; and all the
patients performed their usual activities without symptoms
(mRS 0–1).
Case 1
A 50-year-old man (patient 2) presented with a comatose
mental status. A brain CT revealed attenuated SAH in the pre-
pontine cistern, predominantly in the left side. Diagnostic
angiography revealed a fusiform dissecting aneurysm of the
left VA with hypoplasia of the contralateral VA (Fig 1A). With
the patient under general anesthesia, a 6F Envoy guiding cath-
eter was placed into the distal left VA via the right femoral
artery. Initially, a 3  38 mm Multilink Zeta coronary stent
was deployed across the aneurysm neck, and coil emboliza-
tion was performed. During the procedure, a remodeling bal-
loon (HyperGlide) was placed within the stent to protect the
parent artery (Fig 1B). The final angiography showed com-
plete aneurysm occlusion with a patent VA (Fig 1C). Never-
theless, the patient remained comatose and died 7 days after
the procedure.
Case 2
A40-year-oldwoman (patient 5)was admittedwith SAH (HH
grade 4). Diagnostic angiography revealed a fusiform dissect-
ing aneurysmof the left VA involving the PICAwith antegrade
flow (Fig 2A). With the patient under general anesthesia, a 6F
Envoy guiding catheter was placed into the distal left VA via
the right femoral artery. A 4 20mmNeuroform-2 stent was
deployed across the aneurysmneck, and coil embolizationwas
performed by using a balloon and microcatheter (Fig 2A).
During the procedure, rebleeding occurred because of aneu-
rysmal rupture by coil prolapse, and the balloon was immedi-
ately temporarily occluded to prevent further SAH, followed
by reversal of heparinization by using protamine sulfate (Fig
2C). After verifying that the aneurysmwas no longer bleeding,
we used another stent (Flexmaster, 3  16 mm) to replace
the additional coil. Final angiography showed partial but
satisfactory aneurysm occlusion without bleeding (Fig 2D). At
12months, the aneurysm remained partially occludedwithout
residual sac growth (Fig 2E).
Discussion
The introduction of complex-shaped coils, balloon-assisted
techniques, and intracranial self-expandable stents has facili-
tated the endovascular treatment of complex and surgically
intractable aneurysms, but these aneurysms, nevertheless, re-
main challenging to treat. In particular, immediate treatment
of symptomatic circumferential or fusiform aneurysms, which
incorporate180° of the parent vessel and branching vessels
such as the PICA or AICA, is mandatory.6-8 Although some
authors have treated these complex aneurysms by using surgi-
cal techniques, other authors have reported that internal trap-
ping of the dissecting fusiform aneurysm is one of the most
reliable treatment options.9-13 Anson et al14 reported surgical
treatment of 41 dolichoectatic and fusiform aneurysms in pa-
tients with severe disability. Twenty-three percent of patients
died, and follow-up results showed 17 unclippable wrapped
fusiform aneurysms with 1 minor complication.15 Recently,
Fiorella et al5 introduced a novel balloon-in-stent technique
for constructive endovascular treatment of circumferential
aneurysms.
Fig 1. A 50-year-old man with subarachnoid hemorrhage (SAH). A, The left vertebral artery (VA) angiogram shows a fusiform aneurysm without a branching vessel. The right VA is
hypoplastic (not shown). B, Coil embolization is performed by using a Neuroform stent and balloon. C, Control angiogram shows complete occlusion of the aneurysm.
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Our reconstructive endovascular procedure by using a
combination of a stent and balloon was technically very suc-
cessful (100%) with only 1 periprocedural complication ob-
served among 20 patients (patient 5). Although 2 patients
died, they presented initially with a poor HH grade of 5, and
there was no evidence of postoperative rebleeding or infarc-
tion. Rabinov et al10 reported a 20% postprocedural mortality
rate for destructive endovascular treatment of vertebrobasilar
dissecting aneurysms due to recurrent hemorrhage, vaso-
spasm, global ischemia, or contralateral VA dissection.
Fiorella et al5 described 2 significant retroperitoneal hemato-
mas and 2 brain stem infarcts in their constructive endovas-
cular treatment of circumferential aneurysms by using the
“balloon-in-stent” technique.
TE is one of the unavoidable complications when using a
stent or balloon for endovascular treatment. While some au-
thors have insisted that balloon-assisted techniques increase
the risk of symptomatic and asymptomatic TE, others have
suggested that procedure-related TE can be decreased with
aggressive anticoagulation and antiplatelet therapy.4,16 If this
type of therapy is used, it is necessary to maintain antiplatelet
and anticoagulation therapy both before and after the proce-
dure and to decrease the procedure time if at all possible. In
our symptomatic patients with SAH, we began anticoagula-
tion with heparin immediately after the placement of the
balloon and stent and maintained this therapy for 24 hours
after the procedure. In addition, loading doses of aspirin and
clopidogrel were administered through a nasogastric tube
promptly after coil embolization. However, the requirement
for dual antiplatelet therapy increases the risk of intracranial
hemorrhage and possibly rebleeding from a ruptured aneu-
rysm.17 In our study, 4 patients with SAH required placement
of an external ventricular drain, and 1 patient had a minimal
intracranial hemorrhage along the catheter. Therefore, intra-
cranial procedures such as ventriculostomy accompanied by
dual antiplatelet therapy should be carefully monitored.
Some authors have reported Neuroform stent migration,
which would have serious consequences for stent-assisted
Fig 2. A 40-year-old woman with SAH. A, The left VA angiogram shows the circumferential aneurysm incorporated within the left posterior inferior cerebellar artery. B, The roadmap image
shows the coil inserted into the circumferential aneurysm by using a Neuroform stent and balloon. C, Aneurysmal rebleeding (arrow) occurs during the procedure, and temporary occlusion
of the parent artery is performed by using the balloon. D, After the second stent is placed into the stented parent artery, control angiogram shows partial occlusion of this aneurysm without
rebleeding. E, Control angiogram 12 months after the procedure shows partial occlusion of the aneurysm without regrowth of the residual sac or coil compaction.
158 Suh  AJNR 31  Jan 2010  www.ajnr.org
coiling.18-21 Because most stent migration occurs when the
microguidewire andmicrocatheter are inserted into the aneu-
rysm, some authors prefer using a staged procedure during
stent-assisted coiling to allow the stent to stabilize with endo-
thelization.5,22 However, we performed balloon-assisted coil-
ing immediately after placing the stent across the neck of the
aneurysm, and there were no complications associated with
stent migration. Possible reasons for the lack of complications
are the following: 1) most of our cases involved the vertebro-
basilar arteries, anatomic structures that are not curved but
relatively straight, which may have minimized movement of
the indwelling stent when the balloon catheter was manipu-
lated within the stent; and 2) 15 patients presented with SAH
and required immediate treatment. Above all, the best ap-
proach to prevent stent migration is the use of an oversized
self-expandable stent and placement of the microcatheter
within the aneurysm before stent deployment. It is also neces-
sary to carefully manipulate the microcatheter and balloon
catheter within the stent when catheterizing an aneurysm
through the cells of the stent.
In 1 patient (patient 5) with SAH, aneurysm rebleeding
occurred due to coil prolapse and inadequate manipulation
of the microcatheter. As a rescue remedy, the previously
equipped balloon catheter was inflated to the same diameter as
the parent vessel for 10 minutes and reversion of hepariniza-
tion was performed by using protamine sulfate (50 mg)
through the venous route.When the aneurysmwas confirmed
by angiography to have stopped bleeding, an additional bal-
loon-expandable stent was placed rather than a coil. If we had
not used a preloaded balloon catheter in this case, the parent
vessel and combined branching vessel would have been sacri-
ficed; the preloaded balloon catheter has the unique advantage
of allowing control of intraprocedural aneurysmal bleed-
ing.4,23,24 For ruptured and uncoilable aneurysms, placement
of an additional stent within the stent may reconstruct the
affected aneurysm and dissecting vessel wall by decreasingwall
shear stress, inflow momentum, velocity, and vorticity,
thereby diverting the blood flow into the aneurysm or to the
weakened vascularwall.25-29 Some authors have reportedmul-
tiple and overlapping stent therapy for treatment of uncoilable
aneurysms, such as intradural pseudoaneurysms, blood-blis-
ter-like aneurysms, and dissection.23,30-33
Our study has some limitations. First, the number of pa-
tients enrolled in this study was too small to evaluate the effi-
cacy of our procedure, but fusiform aneurysms are not com-
mon and their management is restricted technically. Second,
coil compaction may be observed in the long-term follow-up
despite good midterm follow-up results. Therefore, it is nec-
essary to perform further hemodynamic studies of fusiform
aneurysms. Hoi et al34 reported that hemodynamics play a
major role in the pathogenesis of BA enlargement. Finally,
additional trials of new therapy to treat IFAs are required,
because incomplete coiling is sometimes necessary to preserve
the parent artery and incorporated vessels. Recently, sole stent
therapy has showed promising results in animalmodels.35-40 A
newly designed stent with low porosity such as a pipeline em-
bolization device may have a major role in the treatment of
circumferential and fusiform aneurysms as well as a saccular
aneurysms.31,38
Conclusions
A 1-stage procedure by using a combination of balloon and
stentmay provide a feasible and safe treatment strategy for the
reconstructive treatment of IFAs that are not amenable to de-
constructive embolization.
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